Herlyn M - Search Results

1

Control of tumor bioenergetics and survival stress signaling by mitochondrial HSP90s.

Chae YC, Caino MC, Lisanti S, Ghosh JC, Dohi T, Danial NN, Villanueva J, Ferrero S, Vaira V, Santambrogio L, Bosari S, Languino LR, Herlyn M, Altieri DC. Chae YC, et al. Among authors: herlyn m. Cancer Cell. 2012 Sep 11;22(3):331-44. doi: 10.1016/j.ccr.2012.07.015. Cancer Cell. 2012. PMID: 22975376 Free PMC article.

2

Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation.

Satyamoorthy K, Li G, Gerrero MR, Brose MS, Volpe P, Weber BL, Van Belle P, Elder DE, Herlyn M. Satyamoorthy K, et al. Among authors: herlyn m. Cancer Res. 2003 Feb 15;63(4):756-9. Cancer Res. 2003. PMID: 12591721

3

Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels.

Smalley KS, Contractor R, Haass NK, Lee JT, Nathanson KL, Medina CA, Flaherty KT, Herlyn M. Smalley KS, et al. Among authors: herlyn m. Br J Cancer. 2007 Feb 12;96(3):445-9. doi: 10.1038/sj.bjc.6603596. Epub 2007 Jan 23. Br J Cancer. 2007. PMID: 17245336 Free PMC article.

4

Mutant V600E BRAF increases hypoxia inducible factor-1alpha expression in melanoma.

Kumar SM, Yu H, Edwards R, Chen L, Kazianis S, Brafford P, Acs G, Herlyn M, Xu X. Kumar SM, et al. Among authors: herlyn m. Cancer Res. 2007 Apr 1;67(7):3177-84. doi: 10.1158/0008-5472.CAN-06-3312. Cancer Res. 2007. PMID: 17409425

5

Learning the ABCs of melanoma-initiating cells.

Zabierowski SE, Herlyn M. Zabierowski SE, et al. Among authors: herlyn m. Cancer Cell. 2008 Mar;13(3):185-7. doi: 10.1016/j.ccr.2008.02.015. Cancer Cell. 2008. PMID: 18328422 Free article.

6

Melanoma and the tumor microenvironment.

Villanueva J, Herlyn M. Villanueva J, et al. Among authors: herlyn m. Curr Oncol Rep. 2008 Sep;10(5):439-46. doi: 10.1007/s11912-008-0067-y. Curr Oncol Rep. 2008. PMID: 18706274 Free PMC article. Review.

7

CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations.

Smalley KS, Xiao M, Villanueva J, Nguyen TK, Flaherty KT, Letrero R, Van Belle P, Elder DE, Wang Y, Nathanson KL, Herlyn M. Smalley KS, et al. Among authors: herlyn m. Oncogene. 2009 Jan 8;28(1):85-94. doi: 10.1038/onc.2008.362. Epub 2008 Sep 15. Oncogene. 2009. PMID: 18794803 Free PMC article.

8

A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.

Roesch A, Fukunaga-Kalabis M, Schmidt EC, Zabierowski SE, Brafford PA, Vultur A, Basu D, Gimotty P, Vogt T, Herlyn M. Roesch A, et al. Among authors: herlyn m. Cell. 2010 May 14;141(4):583-94. doi: 10.1016/j.cell.2010.04.020. Cell. 2010. PMID: 20478252 Free PMC article.

9

BRAF inhibitor unveils its potential against advanced melanoma.

Vultur A, Villanueva J, Herlyn M. Vultur A, et al. Among authors: herlyn m. Cancer Cell. 2010 Oct 19;18(4):301-2. doi: 10.1016/j.ccr.2010.10.001. Cancer Cell. 2010. PMID: 20951940 Free article.

10

Nuclear cyclin D1/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferase.

Aggarwal P, Vaites LP, Kim JK, Mellert H, Gurung B, Nakagawa H, Herlyn M, Hua X, Rustgi AK, McMahon SB, Diehl JA. Aggarwal P, et al. Among authors: herlyn m. Cancer Cell. 2010 Oct 19;18(4):329-40. doi: 10.1016/j.ccr.2010.08.012. Cancer Cell. 2010. PMID: 20951943 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

682 results

Search Page

Filters